2010 Discussions (listed
in reverse chronological order)
Please click HERE to access archived discussions by year posted, and HERE to access archived discussions by topic. You may also use the search tool located in the navigation bar.
Submit a question to the Forum?
Subscribe to the e-Network Forum Newsletter
| Date Posted |
Subject |
| Aug. 11, 2010 |
How many facilities are practicing universal irradiation? |
| Aug. 1, 2010 |
Handling fully tested labeled blood products without wearing gloves |
| July 31, 2010 |
Transporting Freshly Thawed Plasma |
| July 20, 2010 |
Combining Quality Plan with the General Lab? ADDENDA July 31 |
| July 20, 2010 |
Documentation of transfusion start time ADDENDA July 27 & 31 |
| July 20, 2010 |
Selecting donor red cell units for a patient with anti-Jsa that is no longer detectable by routine antibody screening ADDENDA July 26 & 27, Sept 1 |
| July 8, 2010 |
Testing previously pregnant first time platelet donors for anti-HLA and HNA antibodies |
| July 5, 2010 |
Proper controls for EDTA/glycine-acid (EGA) treatment of direct antiglobulin test (DAT) positive red blood cells |
| July 2, 2010 |
Transfusion associated necrotizing enterocolitis? |
| June 20, 2010 |
How do institutions report the findings of antibody identification panels for patients who have received Rh Immune Globulin? ADDENDA Sept. 1 |
| June 9, 2010 |
Antibody titration testing for pregnant women with very weak red cell alloantibodies |
| June 9, 2010 |
REACTIVATED DISCUSSION: Post blood donation seroma formation? ADDENDA Jan. 12 & June 9 |
| May 31, 2010 |
Blood bank computer systems used in transfusion services ADDENDA July 5, 2010 |
| May 31, 2010 |
Deferrals for atherosclerotic disease ADDENDA June 9 |
| May 25, 2010 |
Prophylactic Rh phenotype matching for patients demonstrating anti-E or anti-c; update ADDENDA May 31, June 9 & July 2 |
| May 18, 2010 |
Validity of the antibody screen when using lipemic samples |
| May 18, 2010 |
Update: Which hospital department(s) should manage the storage, dispensing, reconstitution and administration of clotting factor concentrates? |
| May 16, 2010 |
Must a manufacturer's package insert be followed as written, if it is written incorrectly? |
| May 6, 2010 |
Managing neonatal transfusions with a syringe based delivery system - revisited |
| May 6, 2010 |
Update - irradiation of blood products for solid organ transplant recipients |
| May 1, 2010 |
Criteria used for fever as a sign/symptom of a transfusion reaction ADDENDA May 6, 16 & 18 |
| May 1, 2010 |
What is the practice regarding extending storage of thawed FP24 to 5 days? |
| Apr. 28, 2010 |
Interpreting results of testing with monoclonal Jk typing reagents in patients who have a positive direct antiglobulin test |
| Apr. 22, 2010 |
How often should blood administration sets be changed while a patient is being transfused?, revisited |
| Apr. 15, 2010 |
Verifying blood product orders in the laboratory - revisited |
| Mar. 26, 2010 |
Using a rapid test to prevent transfusion of platelets that contain dangerous levels of bacteria ADDENDA April 9 |
| Mar. 13, 2010 |
Work up for a febrile or other adverse event in association with autologous blood administration ADDENDA Mar. 19 |
| Mar. 4, 2010 |
Release of uncrossmatched RBC units - update ADDENDA Mar. 13 |
| Feb. 24, 2010 |
Protocol for using the Mononuclear Monolayer Assay (MMA) |
| Feb. 23, 2010 |
Shelf life of a volume reduced RBC product ADDENDA March 1 & 8 |
| Feb. 17, 2010 |
Agitation of thawed cryoprecipitate that is stored along with platelets at 20-24°C |
| Feb. 15, 2010 |
Blood donations by individuals who are allergic to disinfectants used in arm preps ADDENDA Feb. 21 & 23; Mar. 26 |
| Feb. 3, 2010 |
In search of supplier of coolers for use in blood product transfer to the OR |
| Feb. 3, 2010 |
How to culture units involved in a transfusion reaction investigation ADDENDA Feb. 15 & March 8 |
| Feb. 3, 2010 |
Pregnancy, HTLA antibodies and risk of hemolytic disease of the fetus/newborn |
| Jan. 28, 2010 |
CLSI approved guideline I/LA33-A, Validation of Automated Systems for Immunohematological Testing Before Implementation |
| Jan. 24, 2010 |
Inconsistent Rh typing results |
| Jan. 20, 2010 |
CONTINUED DISCUSSION: Blood Bank Director review and sign-off for antibody investigation, including antibody panels |
| Jan. 20, 2010 |
G-forces and pneumatic tube systems ADDENDA Jan. 30 |
| Jan. 12, 2010 |
"Fibrin clots" in thawed cryoprecipitate ADDENDA Jan. 18 |
| Jan. 7, 2010 |
CONTINUED DISCUSSION: Monitoring blood bank equipment temperatures using wired versus wireless monitoring systems ADDENDA Dec. 29, 2009; Jan. 7, 2010 |
| Jan. 3, 2010 |
Orthopedic surgery and use of 'Component Concentrating Systems' |
| Jan. 3, 2010 |
CONTINUED DISCUSSION: Availability of the Kleihauer-Betke test for work up of fetal bleeding following maternal trauma ADDENDA Jan. 20, Feb. 15 |
| Jan. 2, 2010 |
Re-issuing thawed plasma products that have been returned to the blood bank more than 30 minutes after being issued ADDENDA May 18 & June 11 |
Back to Top 
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
